Study of ISIS 678354 (AKCEA-APOCIII-LRx) in Participants With Hypertriglyceridemia and Established Cardiovascular Disease (CVD)

NCT03385239 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertriglyceridemia
Cardiovascular Diseases

Interventions

DRUG: ISIS 678354
DRUG: Placebo

Sponsor

Akcea Therapeutics

Collaborators

[object Object]